Your browser doesn't support javascript.
loading
Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response.
Colliou, Natacha; Picard, Damien; Caillot, Frédérique; Calbo, Sébastien; Le Corre, Stéphanie; Lim, Annick; Lemercier, Brigitte; Le Mauff, Brigitte; Maho-Vaillant, Maud; Jacquot, Serge; Bedane, Christophe; Bernard, Philippe; Caux, Frédéric; Prost, Catherine; Delaporte, Emmanuel; Doutre, Marie-Sylvie; Dreno, Brigitte; Franck, Nathalie; Ingen-Housz-Oro, Saskia; Chosidow, Olivier; Pauwels, Christine; Picard, Catherine; Roujeau, Jean-Claude; Sigal, Michèle; Tancrede-Bohin, Emmanuelle; Templier, Isabelle; Eming, Rüdiger; Hertl, Michael; D'Incan, Michel; Joly, Pascal; Musette, Philippe.
Affiliation
  • Colliou N; Department of Dermatology, Inserm U905, Institute for Research and Innovation in Biomedicine, Rouen University Hospital, University of Normandy, Rouen 76031, France.
Sci Transl Med ; 5(175): 175ra30, 2013 Mar 06.
Article in En | MEDLINE | ID: mdl-23467561
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: B-Lymphocytes / Pemphigus / Desmogleins / Antibodies, Monoclonal, Murine-Derived Type of study: Risk_factors_studies Limits: Humans Language: En Year: 2013 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: B-Lymphocytes / Pemphigus / Desmogleins / Antibodies, Monoclonal, Murine-Derived Type of study: Risk_factors_studies Limits: Humans Language: En Year: 2013 Type: Article